How to Check Fabtech Technologies IPO Allotment Status?

Fabtech Technologies Limited is a biopharma engineering company designing and delivering turnkey projects including cleanroom facilities, modular systems, and customized engineering solutions, incorporated in 2018, providing end-to-end services encompassing design, engineering, manufacturing, installation, and project management with expertise in cleanroom technology, HVAC systems, and process equipment serving global clients ensuring compliance with international regulatory standards, offering comprehensive services spanning complete bio-pharma manufacturing life cycle from direction setting through product market launch, clean water solutions providing equipment for purified water, pure steam generation and distribution, and water for injections with flow rates ranging from 500 LPH to 50,000 LPH, and clean air solutions supporting life sciences, food and beverage, IT, semiconductor, and aeronautics industries with innovative applications, maintaining in-house software technology capabilities, diversified order book across geographies and business verticals, efficient lead funneling with higher mandate conversion, experienced leadership team with Fabtech Group parentage, employing 185 permanent employees as of July 31, 2025.

The Fabtech Technologies IPO came with a total issue size of ₹230.35 crore, comprising entirely a fresh issue of 1.21 crore shares aggregating to ₹230.35 crore. The IPO opened on September 29, 2025, and closed on October 1, 2025. The allotment for the Fabtech Technologies IPO is expected to be finalized on Friday, October 3, 2025. The Fabtech Technologies IPO share price band was set at ₹181 to ₹191 per share.

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Steps to Check Fabtech Technologies IPO Allotment Status on Registrar Site

• Visit the Bigshare Services Pvt.Ltd. website 
• Select "Fabtech Technologies" from the dropdown menu on the allotment status page
• Enter your PAN ID, Demat Account Number, or Application Number in the designated field
• Complete the captcha verification process and click on the "Submit" button to view your allotment status

Steps to Check Fabtech Technologies IPO Allotment Status on BSE

• Navigate to the BSE SME IPO Allotment Status Page
• Select the issue type: equity/debt
• Choose "Fabtech Technologies" from the list of active IPOs in the dropdown menu
• Input your Application Number and PAN ID in the required fields
• Verify the captcha and click "Search" to check your allotment status

Fabtech Technologies IPO Subscription Status

Fabtech Technologies IPO received moderate investor interest, being subscribed 2.04 times overall. The subscription showed balanced confidence with consistent participation across all categories. Here is a category-wise breakdown of the subscription as of 5:04:43 PM on October 1, 2025:

• Non-Institutional Investors (NII): 1.97 times.
• QIB Category (Ex Anchor): 2.02 times.
• Retail Investors: 2.09 times.
• Employees: 2.01 times.

Fabtech Technologies IPO Share Price and Investment Details

The Fabtech Technologies IPO stock price band was set at ₹181 to ₹191 per share with a minimum lot size of 75 shares. The minimum investment required for retail investors was ₹14,325 for 1 lot (75 shares). The issue included up to 54,945 shares reserved for employees at discount of ₹9.00 per share. Given the moderate subscription response of 2.04 times overall, with balanced institutional interest at 2.02 times, consistent NII participation at 1.97 times, solid retail subscription at 2.09 times, and strong employee participation at 2.01 times, the Fabtech Technologies IPO share price is expected to list with modest premium.

Utilisation of IPO Proceeds

The funds raised through the IPO will be utilised as follows:

• Funding working capital requirements: ₹127.00 crore.
• Pursuing inorganic growth initiatives through acquisitions: ₹30.00 crore.
• General corporate purposes: Remaining amount.

Business Overview

Fabtech Technologies Limited operates as key turnkey engineering solution provider offering integrated solutions with comprehensive service offerings under one roof for global customers in pharma, biotech, and healthcare sectors, in-house software technology capabilities, diversified order book across geographies, clients, and business verticals, proven project execution capabilities across diverse and challenging geographies, efficient lead funneling resulting in higher mandate conversion, track record of executing projects across all dosage forms, and experienced leadership team with Fabtech Group parentage while demonstrating strong financial performance with 46% revenue increase and 70% PAT rise between FY24-FY25, maintaining healthy financial metrics with 30.46% ROE, strong 13.83% PAT margin, and moderate debt-equity ratio of 0.32. The company enjoys specialized positioning in turnkey engineering solutions for biopharma sector with comprehensive capabilities from design through execution, positioned to benefit from India's expanding pharmaceutical manufacturing sector and increasing global demand for compliant cleanroom facilities.